Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Federica Cavallo

1-50 of 153 results

View this query on the Wikidata Query Service
Autologous transplantation and maintenance therapy in multiple myeloma

scientific article published on September 2014
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

scientific article published on 27 May 2008
2011: the immune hallmarks of cancer

scientific article published on 26 January 2011
Classification of current anticancer immunotherapies

scientific article
Vaccines for tumour prevention

scientific article
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.

scientific article
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.

scientific article published on December 2010
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

scientific article published on 11 August 2011
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

scientific article published on 12 January 2011
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

scientific article
p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis

scientific article
Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten

scientific article published on 9 March 2010
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

scientific article published on 20 July 2004
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

scientific article
Consensus nomenclature for CD8(+) T cell phenotypes in cancer

scientific article published on 25 February 2015
State-of-the-art fusion-finder algorithms sensitivity and specificity

scientific article
Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer.

scientific article published on 16 January 2013
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth

scientific article
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma

scientific article
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma

scientific article published on 01 April 2007
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma.

scientific article
Vaccination for treatment and prevention of cancer in animal models.

scientific article
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity

scientific article
Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.

scientific article published in May 1995
The noninflammatory role of high mobility group box 1/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells

scientific article published on 22 August 2013
State of art fusion-finder algorithms are suitable to detect transcription-induced chimeras in normal tissues?

scientific article
Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance

scientific article published on August 2006
Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival

scientific article published on 16 July 2014
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results.

scientific article published on 17 June 2013
Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice

scientific article published on December 2008
Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study

scientific article
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine

scientific article published in June 2004
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins

scientific article published on 23 March 2010
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.

scientific article
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2.

scientific article published on 23 April 2013
Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity

scientific article published in March 2005
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma

scientific article
Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

scientific article
A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients

scientific article published on October 15, 2010
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors

scientific article published on March 17, 2012
Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.

scientific article published in April 2006
Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer

scientific article published on 13 November 2015
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy

scientific article published on 30 April 2010
Are oncoantigens suitable targets for anti-tumour therapy?

scientific article (publication date: September 2007)
Vaccines and other immunological approaches for cancer immunoprevention

scientific article published on December 2011
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells.

scientific article
CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA

scientific article published on 29 May 2014
DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma

article
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

scientific article published on 23 January 2014
Novel insights into Notum and glypicans regulation in colorectal cancer

scientific article published on 20 October 2015

Paulina is supported by:

About Paulina

Help